5 patents currently held
14 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Nov 2027. from the record
Of the 14 now held by other companies, 6 were conveyed to Valo Health Inc. in the filing they arrived in, and 8 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
3
Ending by 2030
Nov 2027
Next term end
3
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Apr 2028 · High confidence
Also notable
Ends Nov 2035 · High confidence
Also notable
Ends Jun 2043 · High confidence
Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals
US 7,795,019
Renewed at every maintenance window since the 2010 grant; no more fees are due before its term ends in 2028.
System For The Concomitant Assessment of Drug Dissolution, Absorption and Permeation and Methods of Using The Same
US 9,546,991
Granted 2017 and renewed at every maintenance window due so far. Protection runs to 2035.
Gabaa Positive Allosteric Modulator Compounds, Methods of Making, and Uses Thereof
US 12,617,794
Granted 2026. Too new for citation comparison; protection runs to 2043.
Formerly held, still cited
Notable
Ends Feb 2040 · High confidence
Cited by 20 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2040.
conveyed to Genentech Inc. - now held by F. Hoffmann-La Roche AG
Also notable
Ends Mar 2033 · High confidence
The most cited patent in this portfolio, cited by 47 later US patents, top 10% of utility patents granted in 2017 in our data. Protection runs to 2033.
conveyed to Genentech Inc. - now held by Valo Health, Inc.
Also notable
Ends Sep 2031 · High confidence
Cited by 17 later US patents, top 25% of utility patents granted in 2019 in our data. Protection runs to 2031.
conveyed to Genentech Inc. - now held by Valo Health, Inc.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 10, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
- 1 term has ended since Aug 16, 2026
What they patent
The 2 largest of its 3 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals | 3 in force | to Apr 2028 |
| Gabaa Positive Allosteric Modulator Compounds, Methods of Making, and Uses Thereof | 1 in force | to Jun 2043 |
Patents held now
Soonest term end first.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,105,828 | Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals In force · High confidence | In force | High confidence | |
| US 8,110,398 | Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals In force · High confidence | In force | High confidence | |
| US 7,795,019 | Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals In force · High confidence | In force | High confidence | |
| US 9,546,991 | System For The Concomitant Assessment of Drug Dissolution, Absorption and Permeation and Methods of Using The Same In force · High confidence | In force | High confidence | |
| US 12,617,794 | Gabaa Positive Allosteric Modulator Compounds, Methods of Making, and Uses Thereof held by Pharmaron Beijing Co. Ltd. (China) In force · High confidence | In force | High confidence |
Also on record, not counted in the 5: 14 patents in force now held by others · 2 patents ended · 5 applications pending · 4 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.